Benitec Biopharma (BNTC) Depreciation and Depletion (2019 - 2023)

Benitec Biopharma has reported Depreciation and Depletion over the past 5 years, most recently at $19000.0 for Q3 2023.

  • Quarterly results put Depreciation and Depletion at $19000.0 for Q3 2023, down 54.76% from a year ago — trailing twelve months through Sep 2023 was $121000.0 (down 22.93% YoY), and the annual figure for FY2022 was $167000.0, down 27.71%.
  • Depreciation and Depletion reached $19000.0 in Q3 2023 per BNTC's latest filing, down from $42000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $67000.0 in Q4 2020 and bottomed at -$105000.0 in Q2 2020.
  • Median Depreciation and Depletion over the past 5 years was $51000.0 (2019), compared with a mean of $36000.0.
  • The largest annual shift saw Depreciation and Depletion skyrocketed 149.52% in 2021 before it crashed 88.46% in 2022.
  • Over 5 years, Depreciation and Depletion stood at $51000.0 in 2019, then skyrocketed by 31.37% to $67000.0 in 2020, then decreased by 17.91% to $55000.0 in 2021, then fell by 23.64% to $42000.0 in 2022, then plummeted by 54.76% to $19000.0 in 2023.
  • Business Quant data shows Depreciation and Depletion for BNTC at $19000.0 in Q3 2023, $42000.0 in Q3 2022, and $6000.0 in Q2 2022.